MedTrace Logo

Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)

NCT06655337 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 417

Last updated 2025-10-03

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate whether the use of the medidux™ smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units (AAU) with non-urgent health complaints. This trial includes adult patients (age ≥ 18) in Emergency Severity Index (ESI) triage system groups 4 (standard) or 5 (non-urgent), presenting with primary symptoms such as cough, back pain, or abdominal discomfort.

The main question it aims to answer is:

Can the medidux™ app reduce the incidence of AAU readmissions, emergency hospitalizations, or consultations with other medical providers within 7 days after initial admission?

Researchers will compare participants using the medidux™ app (intervention arm) with those receiving standard care (control arm) to observe potential differences in the rates of readmissions, emergency hospitalizations, and medical consultations.

Participants will:

* use the medidux™ app to monitor their symptoms and vital parameters for 7 days after discharge (intervention arm).
* receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions (both arms).

Conditions

  • Acute Disease
  • Acute Hospitalization
  • Coughing
  • Back Pain
  • Abdominal Pain (AP)
  • Patient Discharge
  • Patient Readmission
  • Mobile Health Apps
  • Mobile Health Technology (mHealth)
  • Patient Reported Outcome (PRO)

Interventions

DEVICE

Smartphone Application for Post-Discharge Symptom Monitoring

This intervention involves the use of a smartphone application designed for symptom monitoring. The app enables participants to log daily health data, including symptoms and vital signs, for 7 days following discharge. It provides automated prompts and guidance for self-management, including when to seek medical assistance. The app does not provide direct medical intervention but facilitates remote symptom tracking to reduce readmissions and emergency hospitalizations. Follow-up consultations are conducted at day 7 and day 28.

Sponsors & Collaborators

  • Palleos Healthcare GmbH

    collaborator INDUSTRY

  • Mobile Health AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-28
Primary Completion
2027-03-28
Completion
2027-03-28

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655337 on ClinicalTrials.gov